Literature DB >> 12726976

Recurrence in tuberculosis: relapse or reinfection?

Marie-Laurence Lambert1, Epco Hasker, Armand Van Deun, Dominique Roberfroid, Marleen Boelaert, Patrick Van der Stuyft.   

Abstract

The importance of reinfection as a cause for recurrence of tuberculosis is unclear and has potential public-health implications. We systematically searched published material for studies using DNA fingerprinting to provide data on the issue. Very few studies were designed for that particular research objective and/or report on a sufficient number of observations. Differences in methods--eg, case-definitions--seriously hamper comparisons between studies. The proportion of recurrences due to reinfection ranged between 0% and 100%; however, this figure cannot be a useful indicator since the two causes of recurrence--relapse and reinfection--are essentially independent. Only one study provides an estimate of the incidence of recurrence due to reinfection, indicating its importance for HIV-infected patients in an environment with an unusually high tuberculosis incidence. We argue that apart from extreme situations like this one the problem of recurrence of tuberculosis due to reinfection has few implications for tuberculosis-control programmes.

Entities:  

Mesh:

Year:  2003        PMID: 12726976     DOI: 10.1016/s1473-3099(03)00607-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  63 in total

1.  Clostridium difficile mixed infection and reinfection.

Authors:  David W Eyre; A Sarah Walker; David Griffiths; Mark H Wilcox; David H Wyllie; Kate E Dingle; Derrick W Crook; Tim E A Peto
Journal:  J Clin Microbiol       Date:  2011-11-09       Impact factor: 5.948

2.  Models to understand the population-level impact of mixed strain M. tuberculosis infections.

Authors:  Rinat Sergeev; Caroline Colijn; Ted Cohen
Journal:  J Theor Biol       Date:  2011-04-16       Impact factor: 2.691

Review 3.  Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.

Authors:  Jason R Andrews; Farzad Noubary; Rochelle P Walensky; Rodrigo Cerda; Elena Losina; C Robert Horsburgh
Journal:  Clin Infect Dis       Date:  2012-01-19       Impact factor: 9.079

Review 4.  Molecular epidemiology of tuberculosis: current insights.

Authors:  Barun Mathema; Natalia E Kurepina; Pablo J Bifani; Barry N Kreiswirth
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  Exogenous reinfection of tuberculosis in a low-burden area.

Authors:  Consuelo Schiroli; Manuela Carugati; Fabio Zanini; Alessandra Bandera; Silvia Di Nardo Stuppino; Elisa Monge; Manuela Morosi; Andrea Gori; Alberto Matteelli; Luigi Codecasa; Fabio Franzetti
Journal:  Infection       Date:  2015-03-10       Impact factor: 3.553

6.  A nested case-control study on relapse predictors among tuberculosis patients treated in Yemen's NTCP.

Authors:  M S Anaam; M I M Ibrahim; A W Al Serouri; A Bassili; A Aldobhani
Journal:  Public Health Action       Date:  2012-12-21

Review 7.  Mixed-strain mycobacterium tuberculosis infections and the implications for tuberculosis treatment and control.

Authors:  Ted Cohen; Paul D van Helden; Douglas Wilson; Caroline Colijn; Megan M McLaughlin; Ibrahim Abubakar; Robin M Warren
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

8.  The transmission dynamics of tuberculosis in a recently developed Chinese city.

Authors:  Peng Wu; Eric H Y Lau; Benjamin J Cowling; Chi-Chiu Leung; Cheuk-Ming Tam; Gabriel M Leung
Journal:  PLoS One       Date:  2010-05-03       Impact factor: 3.240

9.  Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.

Authors:  Julia D Interrante; Maryam B Haddad; Lindsay Kim; Neel R Gandhi
Journal:  Ann Am Thorac Soc       Date:  2015-11

10.  Risk factors for recurrence after successful treatment of Mycobacterium avium complex lung disease.

Authors:  Bo Young Lee; Sunyoung Kim; YoonKi Hong; Sang-Do Lee; Woo Sung Kim; Dong Soon Kim; Tae Sun Shim; Kyung-Wook Jo
Journal:  Antimicrob Agents Chemother       Date:  2015-03-09       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.